China smartphone shipments slumped in June on inventory overhang: Jefferies
Gillian Beth Zucker, a director at Houlihan Lokey, Inc. (NYSE:HLI), a $11 billion market cap investment advisory firm with impressive 94% gross margins and strong financial health according to InvestingPro, has sold a portion of her holdings in the company, according to a recent SEC filing. On April 14, Zucker sold 200 shares of the company’s Class A common stock at a price of $154.41 per share, totaling $30,882. Following this transaction, Zucker retains 5,401 shares in the investment advisory firm, which has maintained dividend payments for 11 consecutive years and currently offers a 1.5% yield.
The sale was conducted under a Rule 10b5-1 trading plan, which Zucker adopted in May 2024. These plans allow company insiders to set up a predetermined schedule for selling stocks, helping to avoid potential accusations of insider trading. Based on InvestingPro’s analysis, the company appears overvalued at current levels, with additional insights available in the comprehensive Pro Research Report, which provides deep-dive analysis of this and 1,400+ other US stocks.
In other recent news, Houlihan Lokey reported strong financial results for the third quarter of fiscal 2025, with earnings per share (EPS) reaching $1.64, surpassing analyst expectations of $1.49. The company’s revenue also exceeded forecasts, totaling $634 million compared to the anticipated $591.45 million. This performance highlights Houlihan Lokey’s robust growth, particularly in its Corporate Finance segment, which saw a 36% increase in revenue. Additionally, Morgan Stanley (NYSE:MS) upgraded Houlihan Lokey’s stock rating from Underweight to Overweight, although it reduced the price target from $201 to $190. The upgrade was attributed to Houlihan Lokey’s strong management of compensation costs and diversified revenue streams, which are seen as advantageous in navigating market downturns. Meanwhile, Kraft Heinz (NASDAQ:KHC) is reportedly looking to sell its Italian baby food brand, Plasmon, with Houlihan Lokey engaged to facilitate the sale. Binding offers for Plasmon are expected by March. These developments reflect significant strategic moves and financial performance updates for both Houlihan Lokey and Kraft Heinz.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.